Therapy with high-dose statins reduces soluble P-selectin: The impact on plasma fibrin clot properties.

High-dose statin therapy reduces markedly sP-selectin levels in association with improved fibrin clot phenotype, which highlights the contribution of platelet-derived proteins to a prothrombotic state in hypercholesterolemia and statin-induced antithrombotic effects.